Not applicableStudy completedNCT06350903
What this trial is testing
Suppression With Empagliflozin as an Alternative To High-Fat Low-Carbohydrate Diet for Myocardial F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Imaging
Who this might be right for
Myocardial Suppression
Matthieu Pelletier-Galarneau, MD MSc 16